# Bolt Biotherapeutics, Inc.: Form SC 13D/A, filed Feb 12, 2024

- Company: [Bolt Biotherapeutics, Inc.](/companies/bolt.md) (CIK 1641281)
- Form: SC 13D/A
- Filed: 2024-02-12
- Accepted by EDGAR: Feb 12, 2024, 21:41 ET
- Period: not reported
- Accession: 0001193125-24-032572
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1641281/000119312524032572/d773403dsc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1641281/000119312524032572/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1641281/000119312524032572/d773403dsc13da.htm

Filed Feb 12, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-032572. Last ingested by Listed: Nov 13, 2026, 15:45 ET. No prices; not investment advice.
